Ambulatory pulmonary rehabilitation in patients with Covid-19: a challenge in times of pandemic
DOI:
https://doi.org/10.28957/rcmfr.v30spa10Keywords:
Covid-19, Covid-19 rehabilitation, pulmonary rehabilitation program, respiratory rehabilitation, outpatient, Sars-CoV-2Abstract
In the pulmonarysystem, viral diseases show a challenge to the immune condition, in thiscase Coronavirus type 2 of Severe Acute Respiratory Syndrome or Sars-CoV-2. Pulmonary rehabilitation is essential in all patients discharged with Covid-19 as diagnosis, especially those with lung parenchymal involvement, however, there are barriers that put this group at greater risk. Rehabilitation services must implement new measures, integrating virtual technologies, to meet the needs of patients, with the greatest possible objectivity, using among others, pulmonary function tests, within safe parameters. Pulmonary rehabilitation faces the challenge of the outpatient, due to the novelty of this pandemic, there is little evidence on its management. Considering the need for an efficient therapeutic approach, this review article sets out the current pulmonaryrehabilitation evidence recommendations.References
1. Palacios M, Santos E, Velázquez MA, León M. Covid-19, una emergencia de salud pública mundial. Rev Clínica Española [Internet]. 2020;marzo 20. Disponible en: http://doi.org/10.1016/j.rce.2020.03.001
2. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, Mers and novel coronavirus (Covid-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol [Internet]. 2020;49(3):717–726. Disponible en: http://doi.org/10.1093/ije/dyaa033
3. Guan Y, Vijaykrishna D, Bahl J, Zhu H, Wang J, Smith GJD. The emergence of pandemic influenza viruses. Protein Cell. 2010;1(1):9–13. Disponible en: http://doi.org/10.1007/s13238-010-0008-z
4. Taubenberger JK, Morens DM. 1918 Influenza: the Mother of All Pandemics. Emerg Infect Dis [Internet]. 2006;12(1):15–22. Disponible en: http://doi.org/10.3201/eid1209.050979
5. Wu D, Wu T, Liu Q, Yang Z. The Sars-CoV-2 outbreak: What we know. Int J Infect Dis [Internet]. 2020;94:44–48. Disponible en: http://doi.org/10.1016/j.ijid.2020.03.004
6. Tse GM, To K, Chan PK, Lo AW, Ng KC, Wu A, et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol [Internet]. 2004;57(3):260–265. Disponible en: http://dx.doi.org/10.1136/jcp.2003.013276
7. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (Covid-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol [Internet]. 2020;15(5):700–704. Disponible en: http://doi.org/10.1016/j.jtho.2020.02.010
8. Carroll K, Hobden JA, Miller S, Morse SA, Mietzner TA, Detrick B, et al. Jawetz, Melnick, & Adelberg Microbiología médica. 27a. ed. México DF: McGrawHill-Interamericana; 2016. ISBN: 9786071513700
9. Fisher D, Heymann D. Q&A: The novel coronavirus outbreak causing Covid-19. BMC Med [Internet]. 2020;18:57. Disponible en: http://doi.org/10.1186/s12916-020-01533-w
10. Han G-Z. Pangolins Harbor Sars-CoV-2-Related Coronaviruses. Trends Microbiol [Internet]. 2020;28(7):515–517. Disponible en: https://doi.org/10.1016/j.tim.2020.04.001
11. Gralinski LE, BaricRS. Molecular pathology of emerging coronavirusinfections. J Pathol [Internet]. 2015;235(2):185–195. Disponible en: http://doi.wiley.com/10.1002/path.4454
12. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of Covid-19 is higher compared to SARS coronavirus. J Travel Med [Internet]. 2020;27(2):1–4. Disponible en: https://doi.org/10.1093/jtm/taaa021
13. Schellekens BP, Sourrouille D, & World Bank. Tracking Covid-19 as Cause of Death: Global Estimates of Relative Severity [Internet]. Londres: The World Bank Group; 2020 [citado 2020 junio 13]. Reporte: JEL-I10-J11. Disponible en: https://www.brookings.edu/wp-content/uploads/2020/05/Tracking_Covid-19_as_-Cause_of_Death-Global_Estimates_of_Severity.pdf
14. Wu D, Wu T, Liu Q, Yang Z. The Sars-CoV-2 outbreak: What we know. Int J Infect Dis. 2020;94:44–48. Disponible en: http://doi.org/10.1016/j.ijid.2020.03.004
15. World Health Organization [WHO]. Modes of transmission of virus causing Covid-19?: implications for IPC precaution recommendations: scientific brief, 27 march 2020 [Internet]. 2020;marzo 27:1–3.
Disponible en: https://apps.who.int/iris/handle/10665/331601
16. Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SarsCoV-2 receptor. Pharmacol Res [Internet]. 2020;157:104833. Disponible en: http://doi.org/10.1016/j.phrs.2020.104833
17. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a Sars-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med [Internet]. 2020;46(4):586-590. Disponible en: http://doi.org/10.1007/s00134-020-05985-9
18. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner
AJ,et al. Angiotensin-Converting Enzyme 2: Sars-CoV-2 Receptor and Regulator of the Renin-Angiotensin System. Circ Res [Internet]. 2020;126(10):1456–1474. Disponible en: https://doi.org/10.1161/CIRCRESAHA.120.317015
19. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure,replication, and pathogenesis. J Med Virol [Internet]. 2020;92(4):418–423. Disponible en: https://doi.org/10.1002/jmv.25681
20. He J, Tao H, Yan Y, Huang S-Y, Xiao Y. Molecular Mechanism of Evolution and Human Infection with Sars-CoV-2. Viruses [Internet]. 2020;12(4):428. Disponible en: http://doi.org/10.3390/v12040428
21. Chen J, Wu H, Yu Y, Tang N. Pulmonary alveolar regrowth in an adult Covid-19 patient. medRxiv. 2020:mayo 10:20097634. Disponible en: http://doi.org/10.1101/2020.05.10.20097634
22. Bracco L. Covid-19, Type II Alveolar Cells and Surfactant. J Med-Clin Res Rev [Internet]. 2020;4(4):1–3. Disponible en: http://www.scivisionpub.com/pdfs/covid19-type-ii-alveolar-cellsand-surfactant-1137.pdf
23. Groß S, Jahn C, Cushman S, Bär C, Thum T. Sars-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. J Mol Cell Cardiol [Internet]. 2020;144:47–53. Disponible en: http://doi.org/10.1016/j.yjmcc.2020.04.031
24. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of Covid-19 associated with acute respiratory distress syndrome. Lancet Respir Med [Internet]. 2020;8(4):420–422. Disponible en: http://doi.org/10.1016/S2213-2600(20)30076-X
25. Suess C, Hausmann R. Gross and histopathological pulmonary findings in a Covid-19 associated death during self-isolation. Int J Legal Med [Internet]. 2020;134(4):1285–1290. Disponible en: http://doi.org/10.1007/s00414-020-02319-8
26. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med [Internet]. 2020;383(2):120–128. Disponible en: http://www.doi.org/10.1056/NEJMoa2015432h
27. You J, Zhang L, Ni-jia-Ti M, Zhang J, Hu F, Chen L, et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating Covid-19 patients after discharge. J Infect [Internet]. 2020;81(2):e150–e152. Disponible en: http://doi.org/10.1016/j.jinf.2020.06.003
28. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with Covid-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis [Internet]. 2020;20(4):425–434. Disponible en: http://doi.org/10.1016/S1473-3099(20)30086-4
29. Mason RJ. Pathogenesis of COVID from a cell biology
perspective.Eur Resp J. 2020;55(4):2000607. Disponible en: http://doi.org/10.1183/13993003.00607-2020
30. Xie P, Ma W, Tang H, Liu D. Severe Covid-19: A Review of Recent Progress With a Look Toward the Future. Front Public Health [Internet]. 2020;8:189. Disponible en: http://doi.org/10.3389/ fpubh.2020.00189
31. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and Covid-19: the potential role for antifibrotic therapy. Lancet Respir Med [Internet]. 2020;8(8):807–815. Disponible en: http://doi.org/10.1016/ S2213-2600(20)30225-3
32. Severin R, Arena R, Lavie CJ, Bond S, Phillips SA. Respiratory Muscle Performance Screening for Infectious Disease Management Following Covid-19: A Highly Pressurized Situation. Am J Med. 2020;133(9):1025-1032. Disponible en: http://doi.org/10.1016/j.amjmed.2020.04.003
33. Culp WC. Coronavirus Disease 2019: In-Home Isolation Room Construction. A&A Pract [Internet]. 2020;14(6):e01218. Available from: http://journals.lww.com/10.1213 / XAA.0000000000001218. Disponible en: http://doi.org/10.1213/XAA.0000000000001218
34. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh S-C, Yen M-Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2): Facts and myths. J Microbiol Immunol Infect [Internet]. 2020;53(3):404–412. Disponible en: http://doi.org/10.1016/j.jmii.2020.02.012
35. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S, Hayashi K,et al. Estimation of the asymptomatic ratio of novel coronavirus infections (Covid-19). Int J Infect Dis [Internet]. 2020 May;94:154–5. Disponible en: https://doi.org/10.1016/j.ijid.2020.03.020
36. Centers for Disease Control and Prevention [CDC]. Discontinuation of Transmission-Based Precautions and Disposition of Patients with Covid-19 in Healthcare Settings (Interim Guidance) [Internet]. 2020 [citado 2020 junio 15]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html
37. Aytür YK, Ko seog lu BF, Tas kıran OO, Ordu-Go kkaya NK, Delialiog SU, Tur BS, et al. Pulmonary rehabilitation principles in Sars-COV-2 infection (Covid-19): A guideline for the acute and subacute rehabilitation. Turkish J Phys Med Rehabil [Internet]. 2020;66(2):104–120. Disponible en: http://doi.org/10.5606/tftrd.2020.6444h
38. Zhao H-M, Xie Y-X, Wang C. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl) [Internet]. 2020;133(13):1595–15602. Disponible en: http://doi.org/10.1097/CM9.0000000000000848
39. Ahmed H, Patel K, Greenwood D, Halpin S, Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and metaanalysis. J Rehabil Med [Internet]. 2020;52(5):jrm00063.Disponible en: http://doi.org/10.2340/16501977-2694
40. Wu KK, Chan SK, Ma TM. Posttraumatic Stress after SARS. Emerg Infect Dis [Internet]. 2005;11(8):1297–1300. Disponible en: http://doi.org/10.3201/eid1108.041083
41. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic revie and meta-analysis with comparison to the Covid-19 pandemic. The Lancet Psychiatry [Internet]. 2020;7(7):611–627. Disponible en: http://doi.org/10.1016/S2215-0366(20)30203-0
42. Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragon N. Niveles de estrés, ansiedad y depresión en la primera fase del brote del Covid-19 en una muestra recogida en el norte de España. Cad Saude Publica [Internet]. 2020;36(4):e00054020. Disponible en: http://doi.org/10.1590/0102-311x00054020
43. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med [Internet]. 2013;188(8):e13–e64. Disponible en: http://doi.org/10.1164/rccm.201309-1634ST
44. Barker-Davies RM, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-Covid-19 rehabilitation. Br J Sports Med [Internet]. 2020;54(16):949–959. Disponible en:
http://doi.org/10.1136/bjsports-2020-102596
45. Li J. Rehabilitation management of patients with Covid-19: lessons learned from the first experience in China. Eur J Phys Rehabil Med [Internet]. 2020;56(3):335-338. Disponible en: https://doi.org/10.23736/s1973-9087.20.06292-9
46. Sheehy LM. Considerations for Postacute Rehabilitation for Survivors of Covid-19. JMIR Public Health Surveill [Internet]. 2020;6(2):e19462. Disponible en: https://doi.org/10.2196/19462
47. Yang LL, Yang T. Pulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID19). Chronic Dis Transl Med [Internet]. 2020;6(2):79-86. Disponible en: https://doi.org/10.1016/j.cdtm.2020.05.002
48. Mohamed AA, Alawna M. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (Covid-19): A review. Diabetes Metab Syndr. 2020;14(4):489–496. Disponible en: http://doi.org/10.1016/j.dsx.2020.04.038
49. Vitacca M, Carone M, Clini EM, Paneroni M, Lazzeri M, Lanza A, et al. Joint Statement on the Role of Respiratory Rehabilitation in the Covid-19 Crisis: The Italian Position Paper. Respiration [Internet]. 2020;99(6):493–499. Disponible en: http://doi.org/10.1159/000508399
50. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with Covid-19: A randomized controlled study. Complement Ther Clin Pract [Internet]. 2020;39:101166. Disponible en: https://doi.org/10.1016/j.ctcp.2020.101166
51. Bryant MS, Fedson SE, Sharafkhaneh A. Using Telehealth Cardiopulmonary Rehabilitation during the Covid-19 Pandemic. J Med Syst [Internet]. 2020;44(7):125. Disponible en: http://doi.org/10.1007/s10916-020-01593-8
52. Iannaccone S, Castellazzi P, Tettamanti A, Houdayer E, Brugliera L, de Blasio F, et al. Role of Rehabilitation Department for Adult Covid-19 Patients: the Experience of the San Raffaele Hospital of Milan. Arch Phys Med Rehabil [Internet]. 2020;101(98):1656-1661. Disponible en: http://doi.org/10.1016/j.apmr.2020.05.015
53. Raj VS. Covid-19?: We All Have a Role. Arch Phys Med Rehabil [Internet]. 2020;101(8):1471. Disponible en: https://doi.org/10.1016/j.apmr.2020.04.014
54. Batawi S, Tarazan N, Al-Raddadi R, Al Qasim E, Sindi A, Al Johni S, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (Mers). Health Qual Life Outcomes. 2019;17(1):101. Disponible en: https://doi.org/10.1186/s12955-019-1165-2
55. Guo L, Han Y, Li J, Chen Q, Ren Y, Wu Q, et al. Long-term outcomes in patients with severe acute respiratory syndrome treated with oseltamivir: a 12-year longitudinal study. Int J Clin Exp Med. 2019;12(10):12464–12471. Disponible en: http://www.ijcem.com/files/ijcem0074733.pdf
56. Rivera G, Torres R, Fregonezi G, Vilaró J, Puppo H. Challenge for Rehabilitation After Hospitalization for Covid-19. Arch Phys Med Rehabil [Internet]. 2020;101(8):1470–1471. Disponible en: http://doi.org/10.1016/j.apmr.2020.04.013
57. McCormack MC, Kaminsky DA. Pulmonary Function Laboratories: Advice Regarding COVID19 [Internet]. ATS: Disease Related Resources. 2020 [citado 2020 junio 15]. Disponible en: https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/pulmonaryfunction-laboratories.php
2. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, Mers and novel coronavirus (Covid-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol [Internet]. 2020;49(3):717–726. Disponible en: http://doi.org/10.1093/ije/dyaa033
3. Guan Y, Vijaykrishna D, Bahl J, Zhu H, Wang J, Smith GJD. The emergence of pandemic influenza viruses. Protein Cell. 2010;1(1):9–13. Disponible en: http://doi.org/10.1007/s13238-010-0008-z
4. Taubenberger JK, Morens DM. 1918 Influenza: the Mother of All Pandemics. Emerg Infect Dis [Internet]. 2006;12(1):15–22. Disponible en: http://doi.org/10.3201/eid1209.050979
5. Wu D, Wu T, Liu Q, Yang Z. The Sars-CoV-2 outbreak: What we know. Int J Infect Dis [Internet]. 2020;94:44–48. Disponible en: http://doi.org/10.1016/j.ijid.2020.03.004
6. Tse GM, To K, Chan PK, Lo AW, Ng KC, Wu A, et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol [Internet]. 2004;57(3):260–265. Disponible en: http://dx.doi.org/10.1136/jcp.2003.013276
7. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (Covid-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol [Internet]. 2020;15(5):700–704. Disponible en: http://doi.org/10.1016/j.jtho.2020.02.010
8. Carroll K, Hobden JA, Miller S, Morse SA, Mietzner TA, Detrick B, et al. Jawetz, Melnick, & Adelberg Microbiología médica. 27a. ed. México DF: McGrawHill-Interamericana; 2016. ISBN: 9786071513700
9. Fisher D, Heymann D. Q&A: The novel coronavirus outbreak causing Covid-19. BMC Med [Internet]. 2020;18:57. Disponible en: http://doi.org/10.1186/s12916-020-01533-w
10. Han G-Z. Pangolins Harbor Sars-CoV-2-Related Coronaviruses. Trends Microbiol [Internet]. 2020;28(7):515–517. Disponible en: https://doi.org/10.1016/j.tim.2020.04.001
11. Gralinski LE, BaricRS. Molecular pathology of emerging coronavirusinfections. J Pathol [Internet]. 2015;235(2):185–195. Disponible en: http://doi.wiley.com/10.1002/path.4454
12. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of Covid-19 is higher compared to SARS coronavirus. J Travel Med [Internet]. 2020;27(2):1–4. Disponible en: https://doi.org/10.1093/jtm/taaa021
13. Schellekens BP, Sourrouille D, & World Bank. Tracking Covid-19 as Cause of Death: Global Estimates of Relative Severity [Internet]. Londres: The World Bank Group; 2020 [citado 2020 junio 13]. Reporte: JEL-I10-J11. Disponible en: https://www.brookings.edu/wp-content/uploads/2020/05/Tracking_Covid-19_as_-Cause_of_Death-Global_Estimates_of_Severity.pdf
14. Wu D, Wu T, Liu Q, Yang Z. The Sars-CoV-2 outbreak: What we know. Int J Infect Dis. 2020;94:44–48. Disponible en: http://doi.org/10.1016/j.ijid.2020.03.004
15. World Health Organization [WHO]. Modes of transmission of virus causing Covid-19?: implications for IPC precaution recommendations: scientific brief, 27 march 2020 [Internet]. 2020;marzo 27:1–3.
Disponible en: https://apps.who.int/iris/handle/10665/331601
16. Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SarsCoV-2 receptor. Pharmacol Res [Internet]. 2020;157:104833. Disponible en: http://doi.org/10.1016/j.phrs.2020.104833
17. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a Sars-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med [Internet]. 2020;46(4):586-590. Disponible en: http://doi.org/10.1007/s00134-020-05985-9
18. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner
AJ,et al. Angiotensin-Converting Enzyme 2: Sars-CoV-2 Receptor and Regulator of the Renin-Angiotensin System. Circ Res [Internet]. 2020;126(10):1456–1474. Disponible en: https://doi.org/10.1161/CIRCRESAHA.120.317015
19. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure,replication, and pathogenesis. J Med Virol [Internet]. 2020;92(4):418–423. Disponible en: https://doi.org/10.1002/jmv.25681
20. He J, Tao H, Yan Y, Huang S-Y, Xiao Y. Molecular Mechanism of Evolution and Human Infection with Sars-CoV-2. Viruses [Internet]. 2020;12(4):428. Disponible en: http://doi.org/10.3390/v12040428
21. Chen J, Wu H, Yu Y, Tang N. Pulmonary alveolar regrowth in an adult Covid-19 patient. medRxiv. 2020:mayo 10:20097634. Disponible en: http://doi.org/10.1101/2020.05.10.20097634
22. Bracco L. Covid-19, Type II Alveolar Cells and Surfactant. J Med-Clin Res Rev [Internet]. 2020;4(4):1–3. Disponible en: http://www.scivisionpub.com/pdfs/covid19-type-ii-alveolar-cellsand-surfactant-1137.pdf
23. Groß S, Jahn C, Cushman S, Bär C, Thum T. Sars-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. J Mol Cell Cardiol [Internet]. 2020;144:47–53. Disponible en: http://doi.org/10.1016/j.yjmcc.2020.04.031
24. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of Covid-19 associated with acute respiratory distress syndrome. Lancet Respir Med [Internet]. 2020;8(4):420–422. Disponible en: http://doi.org/10.1016/S2213-2600(20)30076-X
25. Suess C, Hausmann R. Gross and histopathological pulmonary findings in a Covid-19 associated death during self-isolation. Int J Legal Med [Internet]. 2020;134(4):1285–1290. Disponible en: http://doi.org/10.1007/s00414-020-02319-8
26. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med [Internet]. 2020;383(2):120–128. Disponible en: http://www.doi.org/10.1056/NEJMoa2015432h
27. You J, Zhang L, Ni-jia-Ti M, Zhang J, Hu F, Chen L, et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating Covid-19 patients after discharge. J Infect [Internet]. 2020;81(2):e150–e152. Disponible en: http://doi.org/10.1016/j.jinf.2020.06.003
28. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with Covid-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis [Internet]. 2020;20(4):425–434. Disponible en: http://doi.org/10.1016/S1473-3099(20)30086-4
29. Mason RJ. Pathogenesis of COVID from a cell biology
perspective.Eur Resp J. 2020;55(4):2000607. Disponible en: http://doi.org/10.1183/13993003.00607-2020
30. Xie P, Ma W, Tang H, Liu D. Severe Covid-19: A Review of Recent Progress With a Look Toward the Future. Front Public Health [Internet]. 2020;8:189. Disponible en: http://doi.org/10.3389/ fpubh.2020.00189
31. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and Covid-19: the potential role for antifibrotic therapy. Lancet Respir Med [Internet]. 2020;8(8):807–815. Disponible en: http://doi.org/10.1016/ S2213-2600(20)30225-3
32. Severin R, Arena R, Lavie CJ, Bond S, Phillips SA. Respiratory Muscle Performance Screening for Infectious Disease Management Following Covid-19: A Highly Pressurized Situation. Am J Med. 2020;133(9):1025-1032. Disponible en: http://doi.org/10.1016/j.amjmed.2020.04.003
33. Culp WC. Coronavirus Disease 2019: In-Home Isolation Room Construction. A&A Pract [Internet]. 2020;14(6):e01218. Available from: http://journals.lww.com/10.1213 / XAA.0000000000001218. Disponible en: http://doi.org/10.1213/XAA.0000000000001218
34. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh S-C, Yen M-Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2): Facts and myths. J Microbiol Immunol Infect [Internet]. 2020;53(3):404–412. Disponible en: http://doi.org/10.1016/j.jmii.2020.02.012
35. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S, Hayashi K,et al. Estimation of the asymptomatic ratio of novel coronavirus infections (Covid-19). Int J Infect Dis [Internet]. 2020 May;94:154–5. Disponible en: https://doi.org/10.1016/j.ijid.2020.03.020
36. Centers for Disease Control and Prevention [CDC]. Discontinuation of Transmission-Based Precautions and Disposition of Patients with Covid-19 in Healthcare Settings (Interim Guidance) [Internet]. 2020 [citado 2020 junio 15]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html
37. Aytür YK, Ko seog lu BF, Tas kıran OO, Ordu-Go kkaya NK, Delialiog SU, Tur BS, et al. Pulmonary rehabilitation principles in Sars-COV-2 infection (Covid-19): A guideline for the acute and subacute rehabilitation. Turkish J Phys Med Rehabil [Internet]. 2020;66(2):104–120. Disponible en: http://doi.org/10.5606/tftrd.2020.6444h
38. Zhao H-M, Xie Y-X, Wang C. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl) [Internet]. 2020;133(13):1595–15602. Disponible en: http://doi.org/10.1097/CM9.0000000000000848
39. Ahmed H, Patel K, Greenwood D, Halpin S, Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and metaanalysis. J Rehabil Med [Internet]. 2020;52(5):jrm00063.Disponible en: http://doi.org/10.2340/16501977-2694
40. Wu KK, Chan SK, Ma TM. Posttraumatic Stress after SARS. Emerg Infect Dis [Internet]. 2005;11(8):1297–1300. Disponible en: http://doi.org/10.3201/eid1108.041083
41. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic revie and meta-analysis with comparison to the Covid-19 pandemic. The Lancet Psychiatry [Internet]. 2020;7(7):611–627. Disponible en: http://doi.org/10.1016/S2215-0366(20)30203-0
42. Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragon N. Niveles de estrés, ansiedad y depresión en la primera fase del brote del Covid-19 en una muestra recogida en el norte de España. Cad Saude Publica [Internet]. 2020;36(4):e00054020. Disponible en: http://doi.org/10.1590/0102-311x00054020
43. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med [Internet]. 2013;188(8):e13–e64. Disponible en: http://doi.org/10.1164/rccm.201309-1634ST
44. Barker-Davies RM, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-Covid-19 rehabilitation. Br J Sports Med [Internet]. 2020;54(16):949–959. Disponible en:
http://doi.org/10.1136/bjsports-2020-102596
45. Li J. Rehabilitation management of patients with Covid-19: lessons learned from the first experience in China. Eur J Phys Rehabil Med [Internet]. 2020;56(3):335-338. Disponible en: https://doi.org/10.23736/s1973-9087.20.06292-9
46. Sheehy LM. Considerations for Postacute Rehabilitation for Survivors of Covid-19. JMIR Public Health Surveill [Internet]. 2020;6(2):e19462. Disponible en: https://doi.org/10.2196/19462
47. Yang LL, Yang T. Pulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID19). Chronic Dis Transl Med [Internet]. 2020;6(2):79-86. Disponible en: https://doi.org/10.1016/j.cdtm.2020.05.002
48. Mohamed AA, Alawna M. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (Covid-19): A review. Diabetes Metab Syndr. 2020;14(4):489–496. Disponible en: http://doi.org/10.1016/j.dsx.2020.04.038
49. Vitacca M, Carone M, Clini EM, Paneroni M, Lazzeri M, Lanza A, et al. Joint Statement on the Role of Respiratory Rehabilitation in the Covid-19 Crisis: The Italian Position Paper. Respiration [Internet]. 2020;99(6):493–499. Disponible en: http://doi.org/10.1159/000508399
50. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with Covid-19: A randomized controlled study. Complement Ther Clin Pract [Internet]. 2020;39:101166. Disponible en: https://doi.org/10.1016/j.ctcp.2020.101166
51. Bryant MS, Fedson SE, Sharafkhaneh A. Using Telehealth Cardiopulmonary Rehabilitation during the Covid-19 Pandemic. J Med Syst [Internet]. 2020;44(7):125. Disponible en: http://doi.org/10.1007/s10916-020-01593-8
52. Iannaccone S, Castellazzi P, Tettamanti A, Houdayer E, Brugliera L, de Blasio F, et al. Role of Rehabilitation Department for Adult Covid-19 Patients: the Experience of the San Raffaele Hospital of Milan. Arch Phys Med Rehabil [Internet]. 2020;101(98):1656-1661. Disponible en: http://doi.org/10.1016/j.apmr.2020.05.015
53. Raj VS. Covid-19?: We All Have a Role. Arch Phys Med Rehabil [Internet]. 2020;101(8):1471. Disponible en: https://doi.org/10.1016/j.apmr.2020.04.014
54. Batawi S, Tarazan N, Al-Raddadi R, Al Qasim E, Sindi A, Al Johni S, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (Mers). Health Qual Life Outcomes. 2019;17(1):101. Disponible en: https://doi.org/10.1186/s12955-019-1165-2
55. Guo L, Han Y, Li J, Chen Q, Ren Y, Wu Q, et al. Long-term outcomes in patients with severe acute respiratory syndrome treated with oseltamivir: a 12-year longitudinal study. Int J Clin Exp Med. 2019;12(10):12464–12471. Disponible en: http://www.ijcem.com/files/ijcem0074733.pdf
56. Rivera G, Torres R, Fregonezi G, Vilaró J, Puppo H. Challenge for Rehabilitation After Hospitalization for Covid-19. Arch Phys Med Rehabil [Internet]. 2020;101(8):1470–1471. Disponible en: http://doi.org/10.1016/j.apmr.2020.04.013
57. McCormack MC, Kaminsky DA. Pulmonary Function Laboratories: Advice Regarding COVID19 [Internet]. ATS: Disease Related Resources. 2020 [citado 2020 junio 15]. Disponible en: https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/pulmonaryfunction-laboratories.php
How to Cite
1.
Bermúdez Escallón JR, Aldana Herrán AC, arra Párraga DLP, Salim Torres YY, Tolosa Cubillos JM. Ambulatory pulmonary rehabilitation in patients with Covid-19: a challenge in times of pandemic. Rev. Colomb. Med. Fis. Rehabil. [Internet]. 2020 Sep. 15 [cited 2024 May 19];30(Supl):130-41. Available from: https://revistacmfr.org/index.php/rcmfr/article/view/256
Downloads
Download data is not yet available.
Downloads
Additional Files
Published
2020-09-15
Issue
Section
Systematic Review